I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
מצבים רפואיים
Breast Neoplasms · Breast Cancer · Breast Tumors · Angiosarcoma · TNBC - Triple-Negative Breast Cancer · HER2-positive Breast Cancer · HER2-negative Breast Cancer · Hormone Receptor Positive Tumor · Hormone Receptor Negative Tumor · Early-stage Breast Cancer · Locally Advanced Breast Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham, Birmingham, Alabama, United States
Contact: Principal Investigator (Erica Stringer-Reasor, MD)Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
Contact: Principal Investigator (Donald Northfelt, MD)University of Arizona, Tucson, Arizona, United States
University of California - Davis, Comprehensive Cancer Center, Davis, California, United States
Contact: Principal Investigator (Mili Arora, MD)City of Hope, Duarte, California, United States
Contact: Principal Investigator (Hope Rugo, MD)University of California San Diego, La Jolla, California, United States
Contact: Principal Investigator (Anne Wallace, MD)University of Southern California, Los Angeles, California, United States
Contact: Principal Investigator (Evanthia Roussos Torres, MD)HOAG Memorial Hospital Presbyterian, Newport Beach, California, United States
Contact: Principal Investigator (Chaitali Nangia, MD)University of California San Francisco (UCSF), San Francisco, California, United States
Contact: Principal Investigator (Amy Jo Chien, MD)University of Colorado Cancer Center, Aurora, Colorado, United States
Anthony Elias, MD (Sub-investigator)Contact: Principal Investigator (Virgnia Borges, MD)Yale Cancer Center, New Haven, Connecticut, United States
Tara Snaft, MD (Sub-investigator)Lajos Pusztai, MD (Sub-investigator)Contact: Principal Investigator (Mariya Rozenblit, MD)Georgetown University Medical Center, Washington D.C., District of Columbia, United States
Contact: Principal Investigator (Claudine Isaacs, MD)H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Contact: Principal Investigator (Hyo Heather Han, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Heather Han, MD)Winship Cancer Institute of Emory University, Atlanta, Georgia, United States
Contact: Principal Investigator (Kevin Kalinsky, MD)University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Rita Nanda, MD)Loyola University, Maywood, Illinois, United States
Contact: Principal Investigator (Kathy S Albain, MD)University of Kansas, Westwood, Kansas, United States
Herbert-Herman Cancer Center, Sparrow Hospital, Lansing, Michigan, United States
Contact: Principal Investigator (Brittani Thomas, DO)University of Minnesota, Minneapolis, Minnesota, United States
Contact: Principal Investigator (Douglas Yee, MD)Mayo Clinic, Rochester, Minnesota, United States
Contact: Principal Investigator (Judy C Boughey, MD)Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park, Minnesota, United States
Contact: Principal Investigator (Satya Bommakanti, MD)Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Contact: Principal Investigator (Coral Omene, MD, PhD)Roswell Park Cancer Institute, Buffalo, New York, United States
Contact: Principal Investigator (Ellis Levine, MD)Laura and Isaac Perlmutter Cancer Center / NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Nancy Chan, MD)Columbia University Medical Center, New York, New York, United States
Contact: Principal Investigator (Meghana Trivedi, MD)University of Rochester Wilmot Cancer Institute, Rochester, New York, United States
Contact: Principal Investigator (Carla Folksm, MD)Montefiore Medical Center, The Bronx, New York, United States
Contact: Principal Investigator (Jesus D Anampa)Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
Contact: Principal Investigator (Marissa Howard-McNatt, MD)Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Julie Lang, MD)The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus, Ohio, United States
Contact: Principal Investigator (Nicole Williams, MD)Oregon Health & Science Institute (OHSU), Portland, Oregon, United States
Contact: Principal Investigator (Alexandra Zimmer, MD)University of Pennsylvania (U Penn), Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Amy Clark, MD)University Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
Sanford Clinical Research, Sioux Falls, South Dakota, United States
Contact: Principal Investigator (Amy Sanford, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
University of Texas, Southwestern Medical Center, Dallas, Texas, United States
University of Texas, M.D. Anderson Cancer Center, Houston, Texas, United States
Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States
Contact: Principal Investigator (Christos Vaklavas, MD)Inova Health System, Falls Church, Virginia, United States
Swedish Cancer Institute, Seattle, Washington, United States
University of Washington, Seattle, Washington, United States
מובילי המחקר
Laura Esserman, MD, MBA
Principal Investigator
University of California, San Francisco